As the science stands, the vast majority of the roughly eight million people in South Africa living with HIV will have to get ...

Recent health data reveals an alarming rise in HIV transmission rate between older men and young women, presenting a complex ...

The strategy, called gene drive, pushes a genetic variant into a population that then retools HSV DNA, which then targets latent, infected neurons. If successful, it would be the second gene therapy ...

Africa has about 25.9 million (65%) of the global burden with Nigeria contributing about 1.9 million making it the fourth ...

Raltegravir Tablets USP, 600 mg are indicated in combination with other antiretroviral agents for the treatment of human ...

Nebraska Aids Project is celebrating 40 years with its annual Night of a Thousand Stars fundraiser. The gala will contribute ...

We need nothing less than disruptive action to ensure everyone who wants access to affordable lenacapavir can get it.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the upcoming presentation of HIV research findings at the International ...

Professor Thumbi Ndung’u from UKZN has been elected to the US National Academy of Medicine, recognising his significant contributions to HIV research ...

HIV is a lifelong condition that currently has no cure. However, there are several things you can do to reduce your risk of contracting HIV or transmitting the virus to others. The primary method of ...

As the leader of an anti-establishment cult who built a devoted following based on his ability to defy the authorities, Mark Christopher has had a bad week or so, writes TOM RAWSTORNE.

The BRAAVE2020 study investigated the efficacy of switching Black Americans living with HIV to a B/F/TAF single-pill regimen.